The commitment includes an additional $50 million to GAVI, the Vaccine Alliance’s Advance Market Commitment for COVID-19 Vaccines and $20 million to the Coalition for Epidemic Preparedness Innovations in support of its efforts to jumpstart the development of an additional slate of promising vaccine candidates….

Goto full post >>